UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two ‘long responder’ case reports and review of the current literature

Journal of international medical research, 2023-09, Vol.51 (9), p.3000605231194881-3000605231194881

Ngan, Roger K. C.

2023

Volltextzugriff (PDF)

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

Scientific reports, 2022-03, Vol.12 (1), p.3803-3803, Article 3803

2022

Volltextzugriff (PDF)

Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma

Oral oncology, 2014-06, Vol.50 (6), p.527-538

2014

Volltextzugriff (PDF)

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4

European journal of cancer (1990), 2022-11, Vol.175, p.236-245

2022

Volltextzugriff (PDF)

Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis

Nature communications, 2024-07, Vol.15 (1), p.5657-11, Article 5657

2024

Volltextzugriff (PDF)

Randomized Trial of Radiotherapy Plus Concurrent–Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma

JNCI : Journal of the National Cancer Institute, 2010-08, Vol.102 (15), p.1188-1198

2010

Volltextzugriff (PDF)

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

European journal of cancer (1990), 2011-03, Vol.47 (5), p.656-666

2011

Volltextzugriff (PDF)

Global comparison of cancer outcomes: standardization and correlation with healthcare expenditures

BMC public health, 2019-08, Vol.19 (1), p.1065-1065, Article 1065

2019

Volltextzugriff (PDF)

Individualized treatment in stage IVC nasopharyngeal carcinoma

Oral oncology, 2014-09, Vol.50 (9), p.791-797

2014

Volltextzugriff (PDF)

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting

International journal of cancer, 2015-02, Vol.136 (4), p.E127-E135

2015

Volltextzugriff (PDF)

The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium

Cancer science, 2021-03, Vol.112 (3), p.1095-1104

2021

Volltextzugriff (PDF)

Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling

Clinical cancer research, 2004-01, Vol.10 (1), p.43-52

2004

Volltextzugriff (PDF)

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Cancer, 2015-08, Vol.121 (16), p.2720-2729

2015

Volltextzugriff (PDF)

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2018777847-3100

2018

Volltextzugriff (PDF)

Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma

JAMA network open, 2023-07, Vol.6 (7), p.e2323890-e2323890

2023

Volltextzugriff (PDF)

Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group

Head & neck, 2005-05, Vol.27 (5), p.397-405

2005

Volltextzugriff (PDF)

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Oral oncology, 2018-02, Vol.77, p.16-21

2018

Volltextzugriff (PDF)

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study

Clinical cancer research, 2021-09, Vol.27 (17), p.4848-4858

2021

Volltextzugriff (PDF)

Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity‐modulated radiotherapy

Asia-Pacific journal of clinical oncology, 2019-02, Vol.15 (1), p.48-55

2019

Volltextzugriff (PDF)

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10‐year outcomes for efficacy and toxicity

Cancer, 2017-11, Vol.123 (21), p.4147-4157

2017

Volltextzugriff (PDF)

ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma

Clinical chemistry (Baltimore, Md.), 2007-02, Vol.53 (2), p.241-250

2007

Volltextzugriff (PDF)

Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons

Radiation oncology (London, England), 2011-05, Vol.6 (1), p.53-53, Article 53

2011

Volltextzugriff (PDF)

NPC‐0501 trial on the value of changing chemoradiotherapy sequence, replacing 5‐fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma

Cancer, 2020-08, Vol.126 (16), p.3674-3688

2020

Volltextzugriff (PDF)

Prophylaxis of radiation-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials

Annals of palliative medicine, 2017-04, Vol.6 (2), p.104-117

2017

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(65)
Humans
(57)
Oncology
(44)
Female
(37)
Male
(33)
Adult
(30)
Middle Aged
(30)
Nasopharyngeal Carcinoma
(23)
Aged
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Cancer
(17)
Tumors
(17)
Chemotherapy
(14)
Nasopharyngeal Neoplasms - Pathology
(14)
Treatment Outcome
(14)
Nasopharyngeal Neoplasms - Drug Therapy
(11)
Nasopharyngeal Neoplasms - Radiotherapy
(11)
Adolescent
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two ‘long responder’ case reports and review of the current literature

A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer

Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4

Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis

Randomized Trial of Radiotherapy Plus Concurrent–Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

Global comparison of cancer outcomes: standardization and correlation with healthcare expenditures

Individualized treatment in stage IVC nasopharyngeal carcinoma

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting

The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium

Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma

Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study

Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity‐modulated radiotherapy

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10‐year outcomes for efficacy and toxicity

ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma

Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons

NPC‐0501 trial on the value of changing chemoradiotherapy sequence, replacing 5‐fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma

Prophylaxis of radiation-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials

Suchergebnisse filtern